Members
Mass Affinity
By Evan Lim
23 September 2026
Mass Affinity is advancing drug discovery for areas of unmet medical need by overcoming the core limitations of traditional methods.
They do this through their proprietary CARMS platform, which identifies binding drugs for targets directly in native biological systems — removing early-stage barriers such as low hit rates, undruggable targets and the complexity of protein purification and assay development to deliver the shortest path to discovery.
